CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients.

Autor: Incoronato, Mariarosaria1 mincoronato@sdn-napoli.it, Mirabelli, Peppino1 pmirabelli@sdn-napoli.it, Catalano, Onofrio1 onofriocatalano@yahoo.it, Aiello, Marco1 marcoaiello1978@gmail.com, Parente, Chiara1 caparente@sdn-napoli.it, Soricelli, Andrea1,2 soricelli@uniparthenope.it, Nicolai, Emanuele1 e.nicolai@sdn-napoli.it
Zdroj: BMC Cancer. 2014, Vol. 14 Issue 1, p426-437. 12p.
Databáze: Academic Search Ultimate